TY - JOUR
T1 - A cluster of mutations in HLA-A2 α2 helix abolishes peptide recognition by T cells
AU - Moots, Robert J.
AU - Matsui, Masanori
AU - Pazmany, Laszlo
AU - McMichael, Andrew J.
AU - Frelinger, Jeffrey A.
PY - 1991/9
Y1 - 1991/9
N2 - In order to investigate the regions of HLA-A2 that control peptide-specific cytotoxic T lymphocyte (CTL) recognition, 37 HLA-A2 genes coding for 50 point mutations that span the α2 helix were synthesized by the technique of saturation mutagenesis. Twenty-nine of these genes, which code for 41 point mutations, were transfected into C1R cells and used as targets in cytotoxicity assays, in the presence of influenza-A matrix peptide 58-68 with specific CTL as effectors. All the transfectants were recognized fully by matrix peptide-specific CTL apart from those with amino acid substitutions at positions 152, 154, 155, 156, or 161, which led to a total loss of recognition and those with mutations at residue 27 or a double mutation at 138 and 150, which were recognized in an intermediate manner. The clustering of the crucial residues that emerges may reflect direct interaction of their side-chains with peptide or the CTL receptor.
AB - In order to investigate the regions of HLA-A2 that control peptide-specific cytotoxic T lymphocyte (CTL) recognition, 37 HLA-A2 genes coding for 50 point mutations that span the α2 helix were synthesized by the technique of saturation mutagenesis. Twenty-nine of these genes, which code for 41 point mutations, were transfected into C1R cells and used as targets in cytotoxicity assays, in the presence of influenza-A matrix peptide 58-68 with specific CTL as effectors. All the transfectants were recognized fully by matrix peptide-specific CTL apart from those with amino acid substitutions at positions 152, 154, 155, 156, or 161, which led to a total loss of recognition and those with mutations at residue 27 or a double mutation at 138 and 150, which were recognized in an intermediate manner. The clustering of the crucial residues that emerges may reflect direct interaction of their side-chains with peptide or the CTL receptor.
UR - http://www.scopus.com/inward/record.url?scp=0025824375&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025824375&partnerID=8YFLogxK
U2 - 10.1007/BF00205816
DO - 10.1007/BF00205816
M3 - Article
C2 - 1894308
AN - SCOPUS:0025824375
SN - 0093-7711
VL - 34
SP - 141
EP - 148
JO - Immunogenetics
JF - Immunogenetics
IS - 3
ER -